P260 Adverse drug reactions and discontinuation rate during the first year on Orkambi - the earliest results of the STORM study

Autor:	R. van der Meer, M. Ploeger, E. Leegwater, M.G.A. van Leeuwen, E. Brokaar
Rok vydání:	2019
Předmět:	Pulmonary and Respiratory Medicine Pediatrics medicine.medical_specialty business.industry Pediatrics Perinatology and Child Health Medicine Storm Drug reaction business medicine.disease Cystic fibrosis Discontinuation
Zdroj:	Journal of Cystic Fibrosis. 18:S130
ISSN:	1569-1993
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9be40039c47c479996c37fb03c226dd2 https://doi.org/10.1016/s1569-1993(19)30553-3 Zobrazit plný text záznamu Full Text from ScienceDirect